Finding the molecular switches behind new infectious diseases
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
More from the blog
Paving the way for greener ammonia production
New MIT research could lead to better materials for a fossil-fuel-free process for making the chemical that's essential to fertilizer and other products.
When AI art has no author: Study finds generated images often can’t be traced to training data
A new method for surgically removing training examples from a model reveals that as datasets grow, the link between what a model learns and what it produces dissolves.
Putting sign language AI into users’ hands
Introducing sign-language-to-text (SL2T), our breakthrough model powering new sign language features for Deaf and hard of hearing users.
The benefits of medical AI assistance vary based on user expertise
Study finds non-experts deferred to LLM-based diagnostic assistance, even when it was wrong, while clinicians caught AI errors.
Related papers
Unlocking non-model organisms with CRISPR-Cas: A roadmap for sustainable biotechnology.
It is concluded that bridging the gap between foundational CRISPR research and its real-world applications is imperative and future efforts should focus on democratizing tools via open-source platforms, advancing delivery systems, and fostering sustainable innovation through synthetic biology integration to fully realize the transformative potential of genome editing in organisms beyond model organisms.
Mutation-induced phenotypic plasticity drives formation of a pro-metastatic tumour-intrinsic niche
It is argued that formation of a tumour-intrinsic niche is a prerequisite for BRAF-mutant CRC seeding to distant organs and that interference with niche formation may help avoid metastatic relapse.
Application of Human Genome Editing Technologies in the Law of Certain States
This article is devoted to the legal regulation of the use of genomic editing technology in individual states. In general, it can be stated that in most legal systems there are restrictions on genomic editing in relation to hereditary genes, however, in rare cases exceptions are allowed, which must be recognized as justified in view of the reality of threats to human life and health. Using the method of comparative legal analysis, the author identifies the most optimal experience that can be useful to the domestic system of law-making on the way to forming legislation in the field of public health protection.